BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 18615476)

  • 1. Novel de novo SHANK3 mutation in autistic patients.
    Gauthier J; Spiegelman D; Piton A; Lafrenière RG; Laurent S; St-Onge J; Lapointe L; Hamdan FF; Cossette P; Mottron L; Fombonne E; Joober R; Marineau C; Drapeau P; Rouleau GA
    Am J Med Genet B Neuropsychiatr Genet; 2009 Apr; 150B(3):421-4. PubMed ID: 18615476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of SHANK3 mutations to autism spectrum disorder.
    Moessner R; Marshall CR; Sutcliffe JS; Skaug J; Pinto D; Vincent J; Zwaigenbaum L; Fernandez B; Roberts W; Szatmari P; Scherer SW
    Am J Hum Genet; 2007 Dec; 81(6):1289-97. PubMed ID: 17999366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism.
    Durand CM; Perroy J; Loll F; Perrais D; Fagni L; Bourgeron T; Montcouquiol M; Sans N
    Mol Psychiatry; 2012 Jan; 17(1):71-84. PubMed ID: 21606927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo SCN2A splice site mutation in a boy with Autism spectrum disorder.
    Tavassoli T; Kolevzon A; Wang AT; Curchack-Lichtin J; Halpern D; Schwartz L; Soffes S; Bush L; Grodberg D; Cai G; Buxbaum JD
    BMC Med Genet; 2014 Mar; 15():35. PubMed ID: 24650168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered spinogenesis in iPSC-derived cortical neurons from patients with autism carrying de novo SHANK3 mutations.
    Gouder L; Vitrac A; Goubran-Botros H; Danckaert A; Tinevez JY; André-Leroux G; Atanasova E; Lemière N; Biton A; Leblond CS; Poulet A; Boland A; Deleuze JF; Benchoua A; Delorme R; Bourgeron T; Cloëz-Tayarani I
    Sci Rep; 2019 Jan; 9(1):94. PubMed ID: 30643170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders.
    Durand CM; Betancur C; Boeckers TM; Bockmann J; Chaste P; Fauchereau F; Nygren G; Rastam M; Gillberg IC; Anckarsäter H; Sponheim E; Goubran-Botros H; Delorme R; Chabane N; Mouren-Simeoni MC; de Mas P; Bieth E; Rogé B; Héron D; Burglen L; Gillberg C; Leboyer M; Bourgeron T
    Nat Genet; 2007 Jan; 39(1):25-7. PubMed ID: 17173049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia.
    Gauthier J; Champagne N; Lafrenière RG; Xiong L; Spiegelman D; Brustein E; Lapointe M; Peng H; Côté M; Noreau A; Hamdan FF; Addington AM; Rapoport JL; Delisi LE; Krebs MO; Joober R; Fathalli F; Mouaffak F; Haghighi AP; Néri C; Dubé MP; Samuels ME; Marineau C; Stone EA; Awadalla P; Barker PA; Carbonetto S; Drapeau P; Rouleau GA;
    Proc Natl Acad Sci U S A; 2010 Apr; 107(17):7863-8. PubMed ID: 20385823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A de novo 1p34.2 microdeletion identifies the synaptic vesicle gene RIMS3 as a novel candidate for autism.
    Kumar RA; Sudi J; Babatz TD; Brune CW; Oswald D; Yen M; Nowak NJ; Cook EH; Christian SL; Dobyns WB
    J Med Genet; 2010 Feb; 47(2):81-90. PubMed ID: 19546099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association study of SHANK3 gene polymorphisms with autism in Chinese Han population.
    Qin J; Jia M; Wang L; Lu T; Ruan Y; Liu J; Guo Y; Zhang J; Yang X; Yue W; Zhang D
    BMC Med Genet; 2009 Jun; 10():61. PubMed ID: 19566951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SHANK3 gene mutations associated with autism facilitate ligand binding to the Shank3 ankyrin repeat region.
    Mameza MG; Dvoretskova E; Bamann M; Hönck HH; Güler T; Boeckers TM; Schoen M; Verpelli C; Sala C; Barsukov I; Dityatev A; Kreienkamp HJ
    J Biol Chem; 2013 Sep; 288(37):26697-708. PubMed ID: 23897824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered Striatal Synaptic Function and Abnormal Behaviour in Shank3 Exon4-9 Deletion Mouse Model of Autism.
    Jaramillo TC; Speed HE; Xuan Z; Reimers JM; Liu S; Powell CM
    Autism Res; 2016 Mar; 9(3):350-75. PubMed ID: 26559786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
    Kim HG; Rosenfeld JA; Scott DA; Bénédicte G; Labonne JD; Brown J; McGuire M; Mahida S; Naidu S; Gutierrez J; Lesca G; des Portes V; Bruel AL; Sorlin A; Xia F; Capri Y; Muller E; McKnight D; Torti E; Rüschendorf F; Hummel O; Islam Z; Kolatkar PR; Layman LC; Ryu D; Kong IK; Madan-Khetarpal S; Kim CH
    Mol Autism; 2019; 10():35. PubMed ID: 31649809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of SHANK3 gene polymorphism and autism.
    Mashayekhi F; Mizban N; Bidabadi E; Salehi Z
    Minerva Pediatr (Torino); 2021 Jun; 73(3):251-255. PubMed ID: 27271042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An autism-linked missense mutation in SHANK3 reveals the modularity of Shank3 function.
    Wang L; Pang K; Han K; Adamski CJ; Wang W; He L; Lai JK; Bondar VV; Duman JG; Richman R; Tolias KF; Barth P; Palzkill T; Liu Z; Holder JL; Zoghbi HY
    Mol Psychiatry; 2020 Oct; 25(10):2534-2555. PubMed ID: 30610205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel splice isoforms for NLGN3 and NLGN4 with possible implications in autism.
    Talebizadeh Z; Lam DY; Theodoro MF; Bittel DC; Lushington GH; Butler MG
    J Med Genet; 2006 May; 43(5):e21. PubMed ID: 16648374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel variants of the SHANK3 gene in Japanese autistic patients with severe delayed speech development.
    Waga C; Okamoto N; Ondo Y; Fukumura-Kato R; Goto Y; Kohsaka S; Uchino S
    Psychiatr Genet; 2011 Aug; 21(4):208-11. PubMed ID: 21378602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copy number and sequence variants implicate APBA2 as an autism candidate gene.
    Babatz TD; Kumar RA; Sudi J; Dobyns WB; Christian SL
    Autism Res; 2009 Dec; 2(6):359-64. PubMed ID: 20029827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced excitatory neurotransmission and mild autism-relevant phenotypes in adolescent Shank3 null mutant mice.
    Yang M; Bozdagi O; Scattoni ML; Wöhr M; Roullet FI; Katz AM; Abrams DN; Kalikhman D; Simon H; Woldeyohannes L; Zhang JY; Harris MJ; Saxena R; Silverman JL; Buxbaum JD; Crawley JN
    J Neurosci; 2012 May; 32(19):6525-41. PubMed ID: 22573675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype and phenotype correlations for SHANK3 de novo mutations in neurodevelopmental disorders.
    Li Y; Jia X; Wu H; Xun G; Ou J; Zhang Q; Li H; Bai T; Hu Z; Zou X; Xia K; Guo H
    Am J Med Genet A; 2018 Dec; 176(12):2668-2676. PubMed ID: 30537371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A strategy to identify de novo mutations in common disorders such as autism and schizophrenia.
    Julie G; Hamdan FF; Rouleau GA
    J Vis Exp; 2011 Jun; (52):. PubMed ID: 21712793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.